Daga Rasha tare da foraunar Amurka: Sputnik V yanzu a Mexico

1. An amince da allurar Coronavirus daga Rasha Sputnik yanzu don amfani da shi a Mexico
2. Sputnik yana da tasiri 91.6%.
3. Alurar rigakafin Sputnik V ta dogara ne akan ingantaccen dandali da aka yi nazari akan ƙwayoyin cuta na adenoviral na ɗan adam, waɗanda ke haifar da mura na gama gari kuma sun kasance a cikin dubban shekaru.

---

Farashin shine kawai $10.00 harbi, kuma yana kare 91.6% daga COVID-19. Waɗannan ƙididdiga ne da Asusun Zuba Jari kai tsaye na Rasha (RDIF, asusun arziƙin mallaka na Rasha) ya buga.

Sputnik rigakafin COVID-19 ne na Rasha da aka yi a yanzu wanda Hukumar Tarayya don Kariya daga Haɗarin Sanitary Mexico (COFEPRIS).

An amince da maganin a ƙarƙashin tsarin izinin amfani da gaggawa ba tare da ƙarin gwaji na asibiti a ƙasar ba. Mexico ta zama ƙasa ta farko ta Arewacin Amurka don amincewa Sputnik V kuma ƙasa ta 17 a duniya.

Kirill Dmitriev, Shugaba na Asusun Zuba Jari na Rasha kai tsaye, ya ce: 

"Muna maraba da shawarar da hukumomin Mexico suka yanke na yin rijistar rigakafin Sputnik V tare da sanya shi a cikin babban fayil ɗin allurar rigakafin cutar coronavirus na ƙasa. Haɗin kai tsakanin Rasha da Mexico zai ceci rayuka da yawa tare da kare jama'a ta hanyar amfani da ɗayan mafi kyawun alluran rigakafi a duniya. An tabbatar da ingancin Sputnik V jiya ta hanyar bayanan da aka buga a ɗaya daga cikin mujallun likitanci da ake girmamawa, The Lancet. "

Sputnik V yana da fa'idodi masu yawa:

• Ingancin Sputnik V shine 91.6% kamar yadda bayanan da aka buga a ciki suka tabbatar The Lancet, daya daga cikin tsofaffin mujallun likitanci kuma mafi girma a duniya; Sputnik V yana ba da cikakkiyar kariya daga mummunan lokuta na COVID-19.
• Alurar rigakafin Sputnik V ta dogara ne akan ingantaccen dandali da aka yi nazari akan ƙwayoyin cuta na adenoviral na ɗan adam, waɗanda ke haifar da mura na gama gari kuma sun kasance a cikin dubban shekaru.
• Sputnik V yana amfani da vectors daban-daban guda biyu daban-daban a hanya na alurar riga kafi, fiye da rigakafin amfani da kayan iskar guda ɗaya.
• An tabbatar da aminci, inganci da rashin tasirin sakamako na dogon lokaci na allurar adenoviral ta hanyar nazarin asibiti sama da 250 sama da shekaru ashirin.
• Masu haɓaka rigakafin Sputnik V suna aiki tare tare da AstraZeneca akan gwajin haɗin gwiwa na asibiti don inganta ingancin rigakafin AstraZeneca.
• Babu wata cuta mai karfi da Sputnik V. ya haifar.
• Yanayin ajiya na Sputnik V a +2+8 C yana nufin ana iya adana shi a cikin firiji na yau da kullun ba tare da wani buƙatar saka hannun jari a cikin ƙarin kayan aikin sanyi ba.
• Farashin Sputnik V bai kai $10 kowane harbi ba, yana mai da shi araha a duk duniya.

Asusun Zuba Jari kai tsaye na Rasha (RDIF) shine asusun arziƙi na Rasha wanda aka kafa a cikin 2011 don yin haɗin gwiwar hannun jari, musamman a cikin Rasha, tare da manyan masu saka hannun jari na kuɗi da dabaru. RDIF yana aiki a matsayin mai samar da saka hannun jari kai tsaye a cikin tattalin arzikin Rasha. Kamfanin gudanarwa na RDIF yana cikin Moscow. A halin yanzu, RDIF yana da gogewa na nasarar aiwatar da ayyukan haɗin gwiwa sama da ayyuka 80 tare da abokan haɗin gwiwar kasashen waje da suka kai sama da RUB2 tn da rufe kashi 95% na yankunan Tarayyar Rasha. Kamfanonin fayil na RDIF suna ɗaukar mutane sama da 800,000 kuma suna samar da kudaden shiga wanda yayi daidai da fiye da kashi 6% na GDP na Rasha. RDIF ta kafa kawancen dabarun hadin gwiwa tare da manyan masu saka hannun jari na kasa da kasa daga kasashe sama da 18 wadanda adadinsu ya haura $40bn. Ana iya samun ƙarin bayani a www.rdif.ru